Search results
Rak podstawnokomórkowy skóry (łac. carcinoma basocellulare, basalioma, ang. basal cell carcinoma, BCC) – najczęstszy nowotwór złośliwy skóry i najczęstszy nowotwór złośliwy u osób rasy białej, charakteryzujący się niskim stopniem złośliwości, powolnym wzrostem i bardzo rzadkim przerzutowaniem.
BCC is diagnosed clinically by the presence of a slowly enlarging skin lesion with typical appearance. The diagnosis and histological subtype is usually confirmed pathologically by a diagnostic biopsy or following excision. Some typical superficial BCCs on trunk and limbs are clinically diagnosed and have non-surgical treatment without histology.
C44.519 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM C44.519 became effective on October 1, 2024. This is the American ICD-10-CM version of C44.519 - other international versions of ICD-10 C44.519 may differ.
4 lip 2020 · Rak podstawnokomórkowy skóry (BCC) wywodzi się keranocytów i zaliczany jest do niebarwnikowych nowotworów skóry. Poznaj objawy i metody leczenia.
Topical therapies (5% imiquimod, 5% fluorouracil) and destructive approaches (curettage, electrocautery, cryotherapy, laser ablation) should be considered in patients with low-risk superficial BCC. Photodynamic therapy is an effective treatment for superficial BCC and thin nodular BCC.
15 wrz 2020 · Superficial BCC is the least invasive of the subtypes and most commonly occur on the trunk and extremities . It appears as a thin scaly plaque resembling eczema or psoriasis, but often retains...
Topical 5-fluorouracil 5% cream is FDA-approved for the treatment of superficial BCC when other treatment options are impractical. This medication is a pyrimidine antimetabolite that interferes with DNA synthesis, inhibits cell proliferation, and causes cell death.
